Form 4: Anterix Inc. Director Thomas R. Kuhn Acquires Shares Through Stock Award

Anterix Inc. Vice Chairman Thomas R. Kuhn acquired 6,574 shares of common stock through a restricted stock award.

Summary

• Thomas R. Kuhn, Vice Chairman of Anterix Inc., acquired 6,574 shares of common stock on December 5, 2024.
• The shares were acquired through a restricted stock award at a price of $0.
• Following the transaction, Mr. Kuhn beneficially owns 10,472 shares of Anterix Inc. common stock.
• The restricted stock vests in full on the earlier of December 5, 2025, or the Issuer's next annual stockholder meeting, with a provision for vesting on the next trading day if the vesting date falls on a closed trading day.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction, which is generally viewed neutrally to slightly positive as it indicates management's alignment with the company's success.

Positives

• The acquisition of shares by a company director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The restricted stock will vest on the earlier of December 5, 2025, or the next annual stockholder meeting, subject to trading policy restrictions.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders acquire or dispose of company stock. It provides transparency into the transactions of company insiders.

Comparison to Industry Standards

• The vesting schedule of the restricted stock is typical for executive compensation packages in publicly traded companies.
• The reporting of the transaction is in line with SEC regulations for insider trading.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows management's confidence in the company.

Key Dates

Keywords

Anterix Inc., stock acquisition, restricted stock, insider trading, beneficial ownership, Thomas R. Kuhn, ATEX